eSpCas9 mRNA(Cap 1,5-MOU)

The eSpCas9 mRNA expresses enhanced-specificity SpCas9 protein, with sequence originally from Slaymaker et al Science. 2015 Dec 1. eSpCas9 is able to reduce off-target effects by over 10-fold, while maintaining robust on-target genome editing efficiency.

产品编号	RP-A00050
规格	0.1 mg 0.2 mg 1 mg 大单询价
数量
价格	￥1000


联系我们

产品简介

产品介绍	The eSpCas9 mRNA expresses enhanced-specificity SpCas9 protein, with sequence originally from Slaymaker et al Science. 2015 Dec 1. eSpCas9 is able to reduce off-target effects by over 10-fold, while maintaining robust on-target genome editing efficiency. This mRNA is capped with Cap1 structure with high capping efficiency. It has 100% substituted with 5-methoxyuridine for enhanced expression and reduced immunogenicity. The mRNA has a 100A tail in its sequence, mimics a mature mRNA.
产品浓度	1mg/mL
存储溶液	1mM Sodium citrate, pH6.5
mRNA序列全长	4479nt
mRNA全长分子量	1458548
储存条件	Store at -20^oC for short term (<3 months), store at – 80 ^oC for long term.